One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Nicholas J. Shears net worth and biography

Nicholas Shears Biography and Net Worth

Insider of Carlisle Companies

Nicholas J. Shears serves as President of Carlisle Construction Materials (CCM) of the Company. Mr. Shears was most recently Executive Vice President, Sales & Marketing for CCM and has held engineering and executive sales and marketing positions at CCM over his 34 years with CCM. Mr. Shears holds a Chemical Engineering degree and an MBA from Penn State University.

What is Nicholas J. Shears' net worth?: The estimated net worth of Nicholas J. Shears is at least $5.92 million as of August 11th, 2022. Mr. Shears owns 15,496 shares of Carlisle Companies stock worth more than $5,919,317 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Shears may own. Learn More about Nicholas J. Shears' net worth.
How do I contact Nicholas J. Shears?: The corporate mailing address for Mr. Shears and other Carlisle Companies executives is 16430 N. SCOTTSDALE RD. SUITE 400, SCOTTSDALE AZ, 85254. Carlisle Companies can also be reached via phone at (480) 781-5000 and via email at [email protected]. Learn More on Nicholas J. Shears' contact information.
Has Nicholas J. Shears been buying or selling shares of Carlisle Companies?: Nicholas J. Shears has not been actively trading shares of Carlisle Companies in the last ninety days. Learn More on Nicholas J. Shears' trading history.
Who are Carlisle Companies' active insiders?: Carlisle Companies' insider roster includes John Berlin (Insider), D. Koch (CEO), Karl Messmer (Insider), Robert Roche (CFO), Scott Selbach (VP), Nicholas Shears (Insider), Lori Snyder (Insider), Douglas Taylor (VP), and Kevin Zdimal (VP). Learn More on Carlisle Companies' active insiders.
Are insiders buying or selling shares of Carlisle Companies?: During the last year, insiders at the conglomerate sold shares 4 times. They sold a total of 15,555 shares worth more than $5,314,571.26. The most recent insider tranaction occured on February, 15th when CEO D Christian Koch sold 6,454 shares worth more than $2,242,958.62. Insiders at Carlisle Companies own 1.5% of the company. Learn More about insider trades at Carlisle Companies.
Information on this page was last updated on 2/15/2024.

Nicholas J. Shears Insider Trading History at Carlisle Companies

Nicholas J. Shears Buying and Selling Activity at Carlisle Companies

Carlisle Companies Company Overview

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, Asia and the Middle East, Africa, and internationally. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company produces single-ply roofing products, and warranted roof systems and accessories, including ethylene propylene diene monomer, thermoplastic polyolefin and polyvinyl chloride membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings. It also offers building envelope solutions, including high-performance waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers, sealants/primers and flashing systems, roof coatings and mastics, spray polyurethane foam and coating systems, block-molded expanded polystyrene insulation, and engineered products for HVAC applications. It sells its products under the Carlisle SynTec, Versico, WeatherBond, Hunter Panels, Resitrix, and Hertalan brands. Carlisle Companies Incorporated was founded in 1917 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $381.99

$364.00

$382.92

50 Day Range

MA: $370.69

$341.84

$400.50

2 Week Range

Now: $381.99

$205.10

$403.44

Volume

458,069 shs

Average Volume

273,590 shs

Market Capitalization

$18.26 billion

P/E Ratio

25.06

Dividend Yield

0.90%

Beta

0.93

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>